Investment involves risk. Past performance is not a reliable indicator of current or future results and should not be the sole factor of consideration when selecting a product or strategy.
SICAV
China Evolution Equity Fund
Seeks to increase the value of its shares, over the long term, through growth in the value of its investments.
ISIN LU2187417386
FACTSHEET
Wenli Zheng is the portfolio manager of the China Evolution Equity Strategy for the International Equity Division. He also co-manages the Greater China portfolio for the International Discovery Strategy. Wenli started his investment career with T. Rowe Price in 2008 as a TMT analyst. Prior to this, Wenli was a strategic consultant with Capgemini.
Overview
Strategy
Fund Summary
Actively managed and invests mainly in a diversified portfolio of shares of Chinese companies and may have significant exposure to smaller capitalisation companies.
Performance - Net of Fees
Past performance is not a reliable indicator of future performance. Performance returns are calculated on a NAV-NAV basis, net of fees, with distributions reinvested. Returns for the current year performance is cumulative. Benchmark returns are shown with reinvestment of dividends after the deduction of withholding taxes. The Excess Returns are shown as Fund % minus the Benchmark %. Performance returns for share classes less than 1 year old (and associated benchmarks) are cumulative rather than annualised.
